Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission

A. M. Carella, E. Gaozza, G. Santini, M. Martinengo, E. Pungolino, G. Piatti, A. Congiu, S. Nati, P. Carlier, D. Giordano, R. Cerri, M. Risso, S. Miceli, M. R. Raffo, D. Scarpati, R. Corvo, P. Franzone, V. Vitale, A. R. Vimercati

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Twenty-five patients with acute non-lymphoblastic leukemia (ANLL) in first complete remission underwent autologous bone marrow transplantation (ABMT) between March 1984 and March 1988. The high-dose therapy employed included cyclophosphamide followed by total body irradiation (10 Gy), administered as a single dose. The median time from complete remission to ABMT was 5 months (range 2-9 months). Thirteen (52%) patients remain in complete remission 10-51 months (median 25 months) after ABMT and 14-60 months (median 32 months) after achieving complete remission. Causes of death were recurrent leukemia (five patients), parenchymal toxicities (acute respiratory distress syndrome, veno-occlusive disease) (three patients), cerebral haemorrhage (one patient), cerebral aspergillosis (one patient) and viral hepatitis (one patient). Six patients relapsed at a median of 5 months after ABMT (range 4-10 months). In conclusion, this study has resulted in survival data comparable to those of other institutions and the best reported outcomes of conventional chemotherapy.

Original languageEnglish
Pages (from-to)537-541
Number of pages5
JournalBone Marrow Transplantation
Volume3
Issue number6
Publication statusPublished - 1988

Fingerprint

Bone Marrow Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Autologous Transplantation
Aspergillosis
Whole-Body Irradiation
Adult Respiratory Distress Syndrome
Cerebral Hemorrhage
Cyclophosphamide
Hepatitis
Cause of Death
Leukemia
Drug Therapy
Survival

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Carella, A. M., Gaozza, E., Santini, G., Martinengo, M., Pungolino, E., Piatti, G., ... Vimercati, A. R. (1988). Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. Bone Marrow Transplantation, 3(6), 537-541.

Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. / Carella, A. M.; Gaozza, E.; Santini, G.; Martinengo, M.; Pungolino, E.; Piatti, G.; Congiu, A.; Nati, S.; Carlier, P.; Giordano, D.; Cerri, R.; Risso, M.; Miceli, S.; Raffo, M. R.; Scarpati, D.; Corvo, R.; Franzone, P.; Vitale, V.; Vimercati, A. R.

In: Bone Marrow Transplantation, Vol. 3, No. 6, 1988, p. 537-541.

Research output: Contribution to journalArticle

Carella, AM, Gaozza, E, Santini, G, Martinengo, M, Pungolino, E, Piatti, G, Congiu, A, Nati, S, Carlier, P, Giordano, D, Cerri, R, Risso, M, Miceli, S, Raffo, MR, Scarpati, D, Corvo, R, Franzone, P, Vitale, V & Vimercati, AR 1988, 'Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission', Bone Marrow Transplantation, vol. 3, no. 6, pp. 537-541.
Carella, A. M. ; Gaozza, E. ; Santini, G. ; Martinengo, M. ; Pungolino, E. ; Piatti, G. ; Congiu, A. ; Nati, S. ; Carlier, P. ; Giordano, D. ; Cerri, R. ; Risso, M. ; Miceli, S. ; Raffo, M. R. ; Scarpati, D. ; Corvo, R. ; Franzone, P. ; Vitale, V. ; Vimercati, A. R. / Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. In: Bone Marrow Transplantation. 1988 ; Vol. 3, No. 6. pp. 537-541.
@article{03935b3ee41141ad96c5eac886fab7d1,
title = "Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission",
abstract = "Twenty-five patients with acute non-lymphoblastic leukemia (ANLL) in first complete remission underwent autologous bone marrow transplantation (ABMT) between March 1984 and March 1988. The high-dose therapy employed included cyclophosphamide followed by total body irradiation (10 Gy), administered as a single dose. The median time from complete remission to ABMT was 5 months (range 2-9 months). Thirteen (52{\%}) patients remain in complete remission 10-51 months (median 25 months) after ABMT and 14-60 months (median 32 months) after achieving complete remission. Causes of death were recurrent leukemia (five patients), parenchymal toxicities (acute respiratory distress syndrome, veno-occlusive disease) (three patients), cerebral haemorrhage (one patient), cerebral aspergillosis (one patient) and viral hepatitis (one patient). Six patients relapsed at a median of 5 months after ABMT (range 4-10 months). In conclusion, this study has resulted in survival data comparable to those of other institutions and the best reported outcomes of conventional chemotherapy.",
author = "Carella, {A. M.} and E. Gaozza and G. Santini and M. Martinengo and E. Pungolino and G. Piatti and A. Congiu and S. Nati and P. Carlier and D. Giordano and R. Cerri and M. Risso and S. Miceli and Raffo, {M. R.} and D. Scarpati and R. Corvo and P. Franzone and V. Vitale and Vimercati, {A. R.}",
year = "1988",
language = "English",
volume = "3",
pages = "537--541",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission

AU - Carella, A. M.

AU - Gaozza, E.

AU - Santini, G.

AU - Martinengo, M.

AU - Pungolino, E.

AU - Piatti, G.

AU - Congiu, A.

AU - Nati, S.

AU - Carlier, P.

AU - Giordano, D.

AU - Cerri, R.

AU - Risso, M.

AU - Miceli, S.

AU - Raffo, M. R.

AU - Scarpati, D.

AU - Corvo, R.

AU - Franzone, P.

AU - Vitale, V.

AU - Vimercati, A. R.

PY - 1988

Y1 - 1988

N2 - Twenty-five patients with acute non-lymphoblastic leukemia (ANLL) in first complete remission underwent autologous bone marrow transplantation (ABMT) between March 1984 and March 1988. The high-dose therapy employed included cyclophosphamide followed by total body irradiation (10 Gy), administered as a single dose. The median time from complete remission to ABMT was 5 months (range 2-9 months). Thirteen (52%) patients remain in complete remission 10-51 months (median 25 months) after ABMT and 14-60 months (median 32 months) after achieving complete remission. Causes of death were recurrent leukemia (five patients), parenchymal toxicities (acute respiratory distress syndrome, veno-occlusive disease) (three patients), cerebral haemorrhage (one patient), cerebral aspergillosis (one patient) and viral hepatitis (one patient). Six patients relapsed at a median of 5 months after ABMT (range 4-10 months). In conclusion, this study has resulted in survival data comparable to those of other institutions and the best reported outcomes of conventional chemotherapy.

AB - Twenty-five patients with acute non-lymphoblastic leukemia (ANLL) in first complete remission underwent autologous bone marrow transplantation (ABMT) between March 1984 and March 1988. The high-dose therapy employed included cyclophosphamide followed by total body irradiation (10 Gy), administered as a single dose. The median time from complete remission to ABMT was 5 months (range 2-9 months). Thirteen (52%) patients remain in complete remission 10-51 months (median 25 months) after ABMT and 14-60 months (median 32 months) after achieving complete remission. Causes of death were recurrent leukemia (five patients), parenchymal toxicities (acute respiratory distress syndrome, veno-occlusive disease) (three patients), cerebral haemorrhage (one patient), cerebral aspergillosis (one patient) and viral hepatitis (one patient). Six patients relapsed at a median of 5 months after ABMT (range 4-10 months). In conclusion, this study has resulted in survival data comparable to those of other institutions and the best reported outcomes of conventional chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0024241483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024241483&partnerID=8YFLogxK

M3 - Article

C2 - 3063322

AN - SCOPUS:0024241483

VL - 3

SP - 537

EP - 541

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 6

ER -